KnowGovRepresentation. Influence. Action.
BillS 1954 · 119

Biosimilar Red Tape Elimination Act

Introduced
Jun 4, 2025
Cosponsors
5
Traction
0
Last Action
Jun 17, 2026

Bill Summary

Removes certain regulatory barriers to make it easier for companies to develop and sell biosimilar drugs, which are cheaper versions of complex medicines.

Sponsored By

Mike Lee
Republican · Utah · Senate

Bill Journey

  1. Jun 4, 2025
  3. Jun 17, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects pharmaceutical companies and patients who use complex medicines, as it could lead to more biosimilar options and lower prices for these drugs.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
5backers
  • Democratic2
  • Republican3
Cross-party cosponsors2 · 50%

Documents

1

Full text opens on congress.gov, the official source.

Cosponsors (5)

1 more not shown here — see the full list on congress.gov.

Bill Details

Bill TypeSenate Bill · Federal
Primary TopicHealth
CommitteeCommittee on Health
IntroducedJun 4, 2025
Last UpdatedJun 17, 2026
Latest ActionCommittee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Subjects
  • Health

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.